Cargando…
Promising Schiff bases in antiviral drug design and discovery
Emerging and re-emerging illnesses will probably present a new hazard of infectious diseases and have fostered the urge to research new antiviral agents. Most of the antiviral agents are analogs of nucleosides and only a few are non-nucleoside antiviral agents. There is quite a less percentage of ma...
Autores principales: | Kaushik, Shikha, Paliwal, Sarvesh Kumar, Iyer, Malliga R., Patil, Vaishali M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171175/ https://www.ncbi.nlm.nih.gov/pubmed/37305208 http://dx.doi.org/10.1007/s00044-023-03068-0 |
Ejemplares similares
-
Rational Design, Synthesis, and Evaluation of Fluorescent CB(2) Receptor Ligands for Live-Cell Imaging: A Comprehensive Review
por: Bhattacharjee, Pinaki, et al.
Publicado: (2023) -
Antiviral peptides as promising therapeutic drugs
por: Vilas Boas, Liana Costa Pereira, et al.
Publicado: (2019) -
Imidazole derivatives: Impact and prospects in antiviral drug discovery
por: Teli, Pankaj, et al.
Publicado: (2022) -
Current Landscape of Antiviral Drug Discovery
por: Blair, Wade, et al.
Publicado: (2016) -
Structure-based Ligand Design and the Promise Held for Antiprotozoan Drug
Discovery
por: Hunter, William N.
Publicado: (2009)